# Correction: Histone acetylation-mediated regulation of the Hippo pathway

**Authors:** Dipanjan Basu, Miguel Reyes-Múgica, Abdelhadi Rebbaa

PMC · DOI: 10.1371/journal.pone.0322605 · PLOS One · 2025-04-09

## Full-text entities

- **Genes:** GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], VIM (vimentin) [NCBI Gene 7431], TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901] {aka BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}
- **Diseases:** cancer (MESH:D009369)
- **Chemicals:** Pyrvinium (MESH:C024631), P (MESH:D010758), Belinostat (MESH:C487081), MTT (MESH:C070243), CM (MESH:D003476), doxorubicin (MESH:D004317)
- **Cell lines:** SW480 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0546), MCF — Homo sapiens (Human), Transformed cell line (CVCL_E778)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11981133/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11981133/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11981133/full.md

---
Source: https://tomesphere.com/paper/PMC11981133